Skip to main content

Table 1 Total health care costs in Denmark year 2016 of all patients ≥ 30 years of age treated for obstructive lung disease

From: Healthcare costs of patients with chronic obstructive pulmonary disease in Denmark – specialist care versus GP care only

Patient population: Means of identification No. Pts n (%) Total costs in 1000 (%) Costs / pt. yr. in Coefficient age & sex adjusted
Specialist care COPD COPD diagnosis code < 5 yrs 46,084 (14) 506,909 (34) 11,605 2.19
GP-care-only COPD Prescription of LAMA or with indication code = COPD 68,471 (21) 344,958 (23) 5,117 1 reference
GP care LABA (Asthma or COPD) Prescription of LABA or ICS/LABA 116,757 (35) 317,589 (21) 2,736 0.70
GP care other R03 (Asthma or COPD) Prescription of other ATC R03 drugs 98,116 (30) 339,421 (22) 3,482 0.83
  1. All included patients fulfilled a prescription on a drug for obstructive lung disease (anatomical therapeutic chemical code R03) in year 2015 or 2016
  2. LAMA Long-acting muscarinic antagonist, LABA Long-acting beta-2-agonist, ICS Inhaled corticosteroid, COPD Chronic obstructive pulmonary disease
  3. The patient populations are hierarchically exclusive of each other. The coefficients are relative per patient costs compared to GP-care-only COPD